About CLB

Established in 2016 in Shenzhen, China, Cheerland Biotechnology (CLB) has established business presence in molecular diagnostics, biologics CDMO, and clinical services, aiming to become a leading biotech enterprise in China and the world.

Led by an international team with extensive experiences in biologics manufacturing, CLB provides global biopharma clients with top-line equipment including the first 15kL bioreactors in China, robust process design, and compliance with cGMP standards and global regulatory requirements. Our mission is to make biomedicine affordable and accessible to worldwide patients through technological innovations and large-scale commercial production.

Currently CLB has subsidiaries in Shenzhen, Beijing, Shanghai, Chengdu and other major cities in China, and offices in the US (Silicon Valley, New York) and Europe (Great Britain).

Cheerland Biotechnology, the World’s Local CDMO.